June 10 was the International #NASHday, this year with the theme NASH Around the World. Quantify is actively engaging in retrospective research in the field of chronic liver disease, and Non-alcoholic Fatty Liver Disease (NAFLD) and non-alcoholic steatohepatitis (NASH), in particular. Quantify has therefore initiated a large retrospective study, HEalth outcomes and Risk Assessment in chronic Liver Disease (HERALD) using comprehensive Swedish data on lab data, Fibroscan results and clinical data, together with Karolinska Universitetssjukhuset Huddinge and Karolinska Institutet, Department of Medicine, Huddinge.
From Quantify’s side, HERALD is led by Oskar Ström and Emilie Toresson Grip – please feel free to reach out to them in case you have any further questions or inquiries with regards to the RWE opportunities with the HERALD data. Read more about HERALD here: https://quantifyresearch.com/liver-disease/